.
.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
http://lm360.us/Roussin-brother-of-Revils-from-Katowice?Ajokusist=191
.
kpcc in person
-
.